1. Home
  2. ALT vs ALMS Comparison

ALT vs ALMS Comparison

Compare ALT & ALMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALT
  • ALMS
  • Stock Information
  • Founded
  • ALT 1997
  • ALMS 2021
  • Country
  • ALT United States
  • ALMS United States
  • Employees
  • ALT N/A
  • ALMS N/A
  • Industry
  • ALT Biotechnology: Pharmaceutical Preparations
  • ALMS
  • Sector
  • ALT Health Care
  • ALMS
  • Exchange
  • ALT Nasdaq
  • ALMS NYSE
  • Market Cap
  • ALT 472.3M
  • ALMS 469.0M
  • IPO Year
  • ALT N/A
  • ALMS 2024
  • Fundamental
  • Price
  • ALT $6.43
  • ALMS $5.17
  • Analyst Decision
  • ALT Strong Buy
  • ALMS Strong Buy
  • Analyst Count
  • ALT 7
  • ALMS 7
  • Target Price
  • ALT $20.83
  • ALMS $28.83
  • AVG Volume (30 Days)
  • ALT 2.0M
  • ALMS 263.6K
  • Earning Date
  • ALT 02-27-2025
  • ALMS 02-28-2025
  • Dividend Yield
  • ALT N/A
  • ALMS N/A
  • EPS Growth
  • ALT N/A
  • ALMS N/A
  • EPS
  • ALT N/A
  • ALMS N/A
  • Revenue
  • ALT $52,000.00
  • ALMS N/A
  • Revenue This Year
  • ALT N/A
  • ALMS N/A
  • Revenue Next Year
  • ALT N/A
  • ALMS N/A
  • P/E Ratio
  • ALT N/A
  • ALMS N/A
  • Revenue Growth
  • ALT N/A
  • ALMS N/A
  • 52 Week Low
  • ALT $5.28
  • ALMS $4.74
  • 52 Week High
  • ALT $14.84
  • ALMS $13.53
  • Technical
  • Relative Strength Index (RSI)
  • ALT 42.82
  • ALMS N/A
  • Support Level
  • ALT $6.06
  • ALMS N/A
  • Resistance Level
  • ALT $7.10
  • ALMS N/A
  • Average True Range (ATR)
  • ALT 0.36
  • ALMS 0.00
  • MACD
  • ALT 0.03
  • ALMS 0.00
  • Stochastic Oscillator
  • ALT 33.33
  • ALMS 0.00

About ALT Altimmune Inc.

Altimmune Inc is engaged in developing treatments for obesity and liver diseases. The Company's pipeline includes next-generation peptide therapeutics for obesity and non-alcoholic steatohepatitis (NASH) (for both, pemvidutide, formerly known as ALT-801), and for chronic hepatitis B (HepTcell). The Company is managed and operates as a single business focused on the research and development of treatments for various diseases and disorders, and vaccines.

About ALMS ALUMIS INC

Alumis Inc is a clinical-stage biopharmaceutical company focused on identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. The Company leverages its proprietary precision data analytics platform, biological insights, and a team of experts with deep experience in precision medicine drug discovery, development, and immunology, to create medicines that significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies.

Share on Social Networks: